dragon pharma anti estrogens
Estrogen management is critical during any aromatising steroid cycle. Our anti-estrogen range includes 6 Dragon Pharma ancillary products covering aromatase inhibitors, selective estrogen receptor modulators, and hair loss prevention.
Aromatase Inhibitors (AIs)
Arimidex (Anastrozole) is the most widely used AI for controlling estrogen levels during testosterone and other aromatising cycles. Aromasin (Exemestane) is a steroidal (suicidal) AI that permanently deactivates the aromatase enzyme, preventing estrogen rebound. Femara (Letrozole) is the strongest AI option, typically reserved for situations requiring aggressive estrogen suppression.
SERMs and Ancillaries
Toremifene is a SERM similar to Nolvadex but with a slightly different receptor binding profile. Raloxifene 60mg is specifically effective for gynecomastia prevention and reduction, often preferred over Nolvadex for this purpose. Finasteride 5mg inhibits 5-alpha reductase to reduce DHT conversion, protecting against androgenic hair loss during cycles.
These ancillaries are essential companion products to any steroid cycle. For post-cycle recovery compounds, see our Post Cycle Therapy section.
Anti Estrogens
Anti Estrogens
Anti Estrogens
Anti Estrogens
Anti Estrogens
Anti Estrogens
Anti Estrogens
Anti Estrogens
Anti Estrogens
Anti Estrogens
Anti Estrogens
Anti Estrogens

